Drug: ranibizumab Quarter: 2016Q3
Total Records: 133 Number of Pages: 7
| DRUGNAME | PT | EventCount |
|---|---|---|
| Ranibizumab | Procedural pain | 10 |
| Ranibizumab | Back pain | 9 |
| Ranibizumab | Concomitant disease aggravated | 8 |
| Ranibizumab | Dry age-related macular degeneration | 8 |
| Ranibizumab | Metamorphopsia | 8 |
| Ranibizumab | Neovascular age-related macular degeneration | 8 |
| Ranibizumab | Retinal degeneration | 8 |
| Ranibizumab | Vision blurred | 8 |
| Ranibizumab | Visual field defect | 8 |
| Ranibizumab | Ankle fracture | 7 |
| Ranibizumab | Chorioretinal atrophy | 7 |
| Ranibizumab | Glaucoma | 7 |
| Ranibizumab | Ocular discomfort | 7 |
| Ranibizumab | Optic disc disorder | 7 |
| RANIBIZUMAB | Pneumonia | 7 |
| Ranibizumab | Retinal exudates | 7 |
| RANIBIZUMAB | Chronic obstructive pulmonary disease | 6 |
| Ranibizumab | Hypertension | 6 |
| RANIBIZUMAB | Pneumothorax | 6 |
| Ranibizumab | Vitreous floaters | 6 |
Total Records: 133 Number of Pages: 7